Brief: Portage Biotech Reports Business And Strategic Update
Jan 4 (Reuters) - Portage Biotech Inc PRTG.O :
* PORTAGE BIOTECH REPORTS BUSINESS AND STRATEGIC UPDATE
* SAYS CO WILL EVALUATE RANGE OF STRATEGIC OPTIONS
* IMPLEMENTING A COST-SAVINGS PLAN THAT INCLUDES A REDUCTION
IN
INTERNAL AND CONTRACTED WORKFORCE
* INKT CLINICAL DEVELOPMENT PAUSED TO FOCUS RESOURCES
* PRIORITIZE ADENOSINE CLINICAL CANDIDATES
* REMAINING EMPLOYEES TO FOCUS PRIMARILY ON PURSUING
ADENOSINE
CLINICAL PROGRAMS
Source text for Eikon: ID:nGNXDzBKw
Further company coverage: PRTG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alpha Compute
See all newsBrief: Alpha Compute Corp. Provides Mid-Q2 2026 Update
Brief: Alpha Compute Ai Gpu Launch Update First Large-Scale Nvidia Blackwell Cluster
Brief: Alpha Compute Appoints Tom Richer To Advisory Board To Accelerate Ai Gpu Compute Infrastructure And Confidential Cloud Strategy
Brief: Alphaton Capital Rebrands As Alpha Compute Corp. To Reflect Its Growing Ai Compute Business
Brief: Alphaton Capital Announces $43 Million Ai Infrastructure And Financing Partnership With Vertical Data